Skip to main content
. 2023 Oct 30;2(4):e144. doi: 10.1002/imt2.144

Figure 2.

Figure 2

Associations between microbiome metabolites and cardiovascular diseases. Short‐chain fatty acids (SCFAs) are generated through the fermentation of indigestible polysaccharides by the gut microbiome and act on specific SCFAs receptors. Trimethylamine (TMA), a metabolite of the gut microbiome, undergoes an oxidation process in the liver via flavin‐containing monooxygenases (FMOs) and is subsequently converted into trimethylamine N‐oxide (TMAO). These metabolites exert both direct and indirect effects on the cardiovascular system, and they have been associated with certain cardiovascular diseases.